Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StaphVAX in cardiovascular surgery patients
NCT00211913Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Jun 2004
- Primary completion
- Oct 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Staphylococcus aureus infection comparing StaphVAX with Placebo (2 arms). Primary endpoint: Serotype-specific antibody concentrations at 6 weeks. Started Jun 2004; status: completed.
02
Drugs
s. aureus type 5 & 8 capsular polysaccharide vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00211913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211913.